Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care

B.R. Nielsen; N.R. Jorgensen; P. Schwarz

Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care

B.R. Nielsen, N.R. Jorgensen, P. Schwarz

Abstract

OBJECTIVES: To investigate the extent of inhaled glucocorticoid (IGC) treatment in general and to what extent general practitioners (GPs) manage the risk of glucocorticoid-induced osteoporosis. METHOD: A questionnaire was sent to all 3,617 GPs in Denmark. RESULTS: The results are divided into criteria for recommending prophylaxis with calcium and vitamin D for patients in actual IGC treatment, routine examinations for osteoporosis before starting asthma or chronic obstructive pulmonary disease (COPD) treatment with IGC, and criteria for starting anti-osteoporotic treatment (bisphosphonates + calcium + vitamin D) for patients in IGC treatment. A total of 535 questionnaires were eligible for evaluation and covered almost 25% of the Danish population. In general, the questionnaires documented that physicians do not use primary nor secondary prophylaxis in their patients treated with IGC with or without risk factors of osteoporosis. CONCLUSION: More studies are warranted to verify the effects of IGC treatment on bone health and the importance of prophylaxis to prevent osteoporosis in IGC-treated patients before outlining specific recommendations for the management of the disease
Udgivelsesdato: 2008/8

Originalsprog	Engelsk
Tidsskrift	Journal of Asthma
Vol/bind	45
Udgave nummer	6
Sider (fra-til)	519-522
Antal sider	3
ISSN	0277-0903
Status	Udgivet - 2008

Citationsformater

@article{81bd91b0064811deb05e000ea68e967b,

title = "Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care",

abstract = "OBJECTIVES: To investigate the extent of inhaled glucocorticoid (IGC) treatment in general and to what extent general practitioners (GPs) manage the risk of glucocorticoid-induced osteoporosis. METHOD: A questionnaire was sent to all 3,617 GPs in Denmark. RESULTS: The results are divided into criteria for recommending prophylaxis with calcium and vitamin D for patients in actual IGC treatment, routine examinations for osteoporosis before starting asthma or chronic obstructive pulmonary disease (COPD) treatment with IGC, and criteria for starting anti-osteoporotic treatment (bisphosphonates + calcium + vitamin D) for patients in IGC treatment. A total of 535 questionnaires were eligible for evaluation and covered almost 25% of the Danish population. In general, the questionnaires documented that physicians do not use primary nor secondary prophylaxis in their patients treated with IGC with or without risk factors of osteoporosis. CONCLUSION: More studies are warranted to verify the effects of IGC treatment on bone health and the importance of prophylaxis to prevent osteoporosis in IGC-treated patients before outlining specific recommendations for the management of the disease Udgivelsesdato: 2008/8",

author = "B.R. Nielsen and N.R. Jorgensen and P. Schwarz",

year = "2008",

language = "English",

volume = "45",

pages = "519--522",

journal = "Journal of Asthma",

issn = "0277-0903",

publisher = "Taylor & Francis",

number = "6",

}

TY - JOUR

T1 - Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care

AU - Nielsen, B.R.

AU - Jorgensen, N.R.

AU - Schwarz, P.

PY - 2008

Y1 - 2008

N2 - OBJECTIVES: To investigate the extent of inhaled glucocorticoid (IGC) treatment in general and to what extent general practitioners (GPs) manage the risk of glucocorticoid-induced osteoporosis. METHOD: A questionnaire was sent to all 3,617 GPs in Denmark. RESULTS: The results are divided into criteria for recommending prophylaxis with calcium and vitamin D for patients in actual IGC treatment, routine examinations for osteoporosis before starting asthma or chronic obstructive pulmonary disease (COPD) treatment with IGC, and criteria for starting anti-osteoporotic treatment (bisphosphonates + calcium + vitamin D) for patients in IGC treatment. A total of 535 questionnaires were eligible for evaluation and covered almost 25% of the Danish population. In general, the questionnaires documented that physicians do not use primary nor secondary prophylaxis in their patients treated with IGC with or without risk factors of osteoporosis. CONCLUSION: More studies are warranted to verify the effects of IGC treatment on bone health and the importance of prophylaxis to prevent osteoporosis in IGC-treated patients before outlining specific recommendations for the management of the disease Udgivelsesdato: 2008/8

AB - OBJECTIVES: To investigate the extent of inhaled glucocorticoid (IGC) treatment in general and to what extent general practitioners (GPs) manage the risk of glucocorticoid-induced osteoporosis. METHOD: A questionnaire was sent to all 3,617 GPs in Denmark. RESULTS: The results are divided into criteria for recommending prophylaxis with calcium and vitamin D for patients in actual IGC treatment, routine examinations for osteoporosis before starting asthma or chronic obstructive pulmonary disease (COPD) treatment with IGC, and criteria for starting anti-osteoporotic treatment (bisphosphonates + calcium + vitamin D) for patients in IGC treatment. A total of 535 questionnaires were eligible for evaluation and covered almost 25% of the Danish population. In general, the questionnaires documented that physicians do not use primary nor secondary prophylaxis in their patients treated with IGC with or without risk factors of osteoporosis. CONCLUSION: More studies are warranted to verify the effects of IGC treatment on bone health and the importance of prophylaxis to prevent osteoporosis in IGC-treated patients before outlining specific recommendations for the management of the disease Udgivelsesdato: 2008/8

M3 - Journal article

SN - 0277-0903

VL - 45

SP - 519

EP - 522

JO - Journal of Asthma

JF - Journal of Asthma

IS - 6

ER -